223 related articles for article (PubMed ID: 15743529)
1. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
Caldas H; Honsey LE; Altura RA
Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
[TBL] [Abstract][Full Text] [Related]
2. Exonization of Alu-generated splice variants in the survivin gene of human and non-human primates.
Mola G; Vela E; Fernández-Figueras MT; Isamat M; Muñoz-Mármol AM
J Mol Biol; 2007 Mar; 366(4):1055-63. PubMed ID: 17204284
[TBL] [Abstract][Full Text] [Related]
3. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.
Wang HW; Sharp TV; Koumi A; Koentges G; Boshoff C
EMBO J; 2002 Jun; 21(11):2602-15. PubMed ID: 12032073
[TBL] [Abstract][Full Text] [Related]
5. Survivin: an inhibitor of apoptosis in pediatric cancer.
Fangusaro JR; Caldas H; Jiang Y; Altura RA
Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
[TBL] [Abstract][Full Text] [Related]
6. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.
Hu H; Shikama Y; Matsuoka I; Kimura J
J Leukoc Biol; 2008 Feb; 83(2):393-400. PubMed ID: 17965335
[TBL] [Abstract][Full Text] [Related]
7. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
8. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
10. Differential subcellular localization of functionally divergent survivin splice variants.
Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
[TBL] [Abstract][Full Text] [Related]
11. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
13. Survivin splice variants regulate the balance between proliferation and cell death.
Caldas H; Jiang Y; Holloway MP; Fangusaro J; Mahotka C; Conway EM; Altura RA
Oncogene; 2005 Mar; 24(12):1994-2007. PubMed ID: 15688031
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
15. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D
Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905
[TBL] [Abstract][Full Text] [Related]
16. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel splice variant of the human anti-apoptopsis gene survivin.
Badran A; Yoshida A; Ishikawa K; Goi T; Yamaguchi A; Ueda T; Inuzuka M
Biochem Biophys Res Commun; 2004 Feb; 314(3):902-7. PubMed ID: 14741722
[TBL] [Abstract][Full Text] [Related]
19. Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis.
Marconi A; Dallaglio K; Lotti R; Vaschieri C; Truzzi F; Fantini F; Pincelli C
Stem Cells; 2007 Jan; 25(1):149-55. PubMed ID: 17008426
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
